Biden administration provides details on COVID-19 strategies for vaccination, cost reimbursement

Feb 02, 2021 - 03:49 PM
COVID19 Web Sized

President Biden today announced details on several initiatives designed to combat COVID-19. The administration is expanding the supply of vaccines, upping the number of weekly allocated doses to 10.5 million.

This minimum supply level will be maintained for the next three weeks, after which the Biden administration hopes to increase the number of available doses.   

Meanwhile, the administration is kicking off phase 1 of its federal retail pharmacy program for vaccinating local communities against COVID-19. At the outset, the public-private partnership will enlist 21 national pharmacy partners, as well as networks of independent pharmacies, as vaccination sites.

President Biden also directed the Federal Emergency Management Agency to fully reimburse states for the use of National Guard personnel and other emergency costs, a move that was originally announced several days after the inauguration. The estimated reimbursement is expected to total $3 billion to $5 billion, which is separate from the $350 billion Biden requested from Congress in currently discussed relief legislation.

Related News Articles

Headline
CDC encourages older adults to get additional COVID-19 vaccine dose 
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
NASEM releases evidence review on COVID-19 vaccine safety
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
FDA approves combo test for flu, COVID-19; alerts providers to medical device risks 
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
CDC recommends additional dose of updated COVID-19 vaccine for older adults
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
FDA: Paxlovid no longer labeled for emergency use after March 8
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
CDC study finds low rates of COVID-19, flu and RSV vaccinations in adults 
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…